Search
for
Sort by
Research 721–750 of 1000+
- Side effects of common acne treatments
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Alternative uses of dermoscopy in daily clinical practice: An update
- Syphilis: A great imitator
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- The Clinical Presentation of Systemic Lupus Erythematosus
- Madarosis
- Profile of dermatological consultations in Brazil (2018)
- A Clinical Approach to Severe Insulin Resistance
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- Bariatric Surgery and Its Effects on the Skin and Skin Diseases
- Hair loss in elderly women
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Psychotropic Medication and Drug-Related Alopecia
- Tissue engineering strategies for human hair follicle regeneration: How far from a hairy goal?
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies
- Lymphocytic mediated alopecia: histological classification by pattern analysis
- Recent advances in the treatment of psoriasis
- Parkinson's disease and skin
- Scalp Itch: A Systematic Review
- Hypersensitivity Reactions to Anticoagulant Drugs
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases